Patent · US Expired

Controlled release bupropion formulation

US6210716A · kind A · utility

43Cited by
36References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 1999
Grant dateApr 3, 2001
Priority date
Expiry dateFeb 26, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/5084
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A controlled release dosage form of bupropion hydrochloride which comprises: PA1 (a) a first pellet having a core of bupropion hydrochloride and hydroxypropyl methylcellulose at a weight ratio of 10:1 to 30:1 and a coating of a mixture of an acrylic resin which is soluble in acidic media and ethyl cellulose; PA1 (b) a second pellet having a core of bupropion hydrochloride and hydroxypropyl methylcellulose at a ratio of 10:1 to 30:1; an inner coating of a mixture of an acrylic resin which is soluble in acidic media and a water insoluble polymer and an outer coating which comprises an enteric coating polymer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.